title: Letter in reply on Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
authors.affiliation: Department of Endocrinology and Diabetes Center, 'G Gennimatas' General Hospital, Athens, Greece.
authors.forename: Labrini
authors.initials: L
authors.lastname: Papanastasiou
authors.forename: Alexandros
authors.initials: A
authors.lastname: Gryparis
authors.forename: George
authors.initials: G
authors.lastname: Piaditis
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications*; D006973:Hypertension / Q000150:complications*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D000451:Mineralocorticoid Receptor Antagonists